Watch Ticker

Orgenesis Inc. Common Stock

Go to Orgenesis Inc. Common Stock Website

$0.53

(%)

Live

Previous Close

$0.527

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$18.1 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approa...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Orgenesis Inc. - Orgenesis Provides Year End Business Update

Major transformation underway commencing with recent acquisitionreasserting full ownership and control over Octomera

Related tickers: ORGS.

Read Full Article

Orgenesis Inc. - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility

ORMOND BEACH, Fla. and GERMANTOWN, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and strategic partnership aimed at advancing Orgenesis’ therapeutic programs and its suite of product development and GMP cell processing services. The collaboration’s goal is to transform the production of cell and gene therapies, making these vital treatments more affordable and accessible to patients worldwide.

Related tickers: ORGS.

Read Full Article

Trending Tickers

LASE

XNAS

$2.04

(%)

PACW

XNAS

$7.54

(%)

SMFL

XNAS

$3.58

(%)

XNYS

$0.00

(%)

MLGO

XNAS

$0.00

(%)